These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 36765726)

  • 1. Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy?
    Benkhaled S; Peters C; Jullian N; Arsenijevic T; Navez J; Van Gestel D; Moretti L; Van Laethem JL; Bouchart C
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy and pancreatic cancer: unique challenges and potential opportunities.
    Young K; Hughes DJ; Cunningham D; Starling N
    Ther Adv Med Oncol; 2018; 10():1758835918816281. PubMed ID: 30574212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and Future Perspectives of Immunotherapy in Pancreatic Cancer.
    Wandmacher AM; Letsch A; Sebens S
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming the limitations of immunotherapy in pancreatic ductal adenocarcinoma: Combining radiotherapy and metabolic targeting therapy.
    Zhang H; Xu W; Zhu H; Chen X; Tsai HI
    J Cancer; 2024; 15(7):2003-2023. PubMed ID: 38434964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.
    Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma.
    Fan JQ; Wang MF; Chen HL; Shang D; Das JK; Song J
    Mol Cancer; 2020 Feb; 19(1):32. PubMed ID: 32061257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination immunotherapy for pancreatic cancer: challenges and future considerations.
    Gössling GCL; Zhen DB; Pillarisetty VG; Chiorean EG
    Expert Rev Clin Immunol; 2022 Nov; 18(11):1173-1186. PubMed ID: 36045547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle.
    Gajiwala S; Torgeson A; Garrido-Laguna I; Kinsey C; Lloyd S
    J Gastrointest Oncol; 2018 Dec; 9(6):1014-1026. PubMed ID: 30603120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Immune Checkpoint Inhibitors in Metastatic Pancreatic Cancer: Current State and Outlook.
    Tran LC; Özdemir BC; Berger MD
    Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview.
    Panchal K; Sahoo RK; Gupta U; Chaurasiya A
    Int Immunopharmacol; 2021 Jun; 95():107508. PubMed ID: 33725635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell response in the syngeneic mouse model.
    Wang R; Chen J; Wang W; Zhao Z; Wang H; Liu S; Li F; Wan Y; Yin J; Wang R; Li Y; Zhang C; Zhang H; Cao Y
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35086948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming the Tumor Microenvironmental Barriers of Pancreatic Ductal Adenocarcinomas for Achieving Better Treatment Outcomes.
    Alzhrani R; Alsaab HO; Vanamal K; Bhise K; Tatiparti K; Barari A; Sau S; Iyer AK
    Adv Ther (Weinh); 2021 Jun; 4(6):. PubMed ID: 34212073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma.
    Chouari T; La Costa FS; Merali N; Jessel MD; Sivakumar S; Annels N; Frampton AE
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic Strategies in Pancreatic Cancer: Making
    Ullman NA; Burchard PR; Dunne RF; Linehan DC
    J Clin Oncol; 2022 Aug; 40(24):2789-2805. PubMed ID: 35839445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions.
    Herting CJ; Karpovsky I; Lesinski GB
    Cancer Metastasis Rev; 2021 Sep; 40(3):675-689. PubMed ID: 34591240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components.
    Hsu SK; Jadhao M; Liao WT; Chang WT; Hung CT; Chiu CC
    Front Mol Biosci; 2022; 9():1020888. PubMed ID: 36299300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic Cancer and Immunotherapy: A Clinical Overview.
    Timmer FEF; Geboers B; Nieuwenhuizen S; Dijkstra M; Schouten EAC; Puijk RS; de Vries JJJ; van den Tol MP; Bruynzeel AME; Streppel MM; Wilmink JW; van der Vliet HJ; Meijerink MR; Scheffer HJ; de Gruijl TD
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapeutic approach for advanced pancreatic adenocarcinoma.
    Kaur J; Mir T; Gill R; Duong J; Marcus S; Khan R
    Immunotherapy; 2021 Jun; 13(9):767-782. PubMed ID: 33910383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microenvironmental Determinants of Pancreatic Cancer.
    Hessmann E; Buchholz SM; Demir IE; Singh SK; Gress TM; Ellenrieder V; Neesse A
    Physiol Rev; 2020 Oct; 100(4):1707-1751. PubMed ID: 32297835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.